Eaton Vance Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.99M | Hold |
121,514
| – | – | ﹤0.01% | 923 |
|
|
2022
Q2 | $2.94M | Hold |
121,514
| – | – | ﹤0.01% | 957 |
|
|
2022
Q1 | $3.13M | Hold |
121,514
| – | – | ﹤0.01% | 1034 |
|
|
2021
Q4 | $3.77M | Sell |
121,514
-56,207
| -32% | -$1.74M | ﹤0.01% | 855 |
|
|
2021
Q3 | $4.31M | Hold |
177,721
| – | – | 0.01% | 756 |
|
|
2021
Q2 | $2.59M | Buy |
177,721
+135,606
| +322% | +$1.98M | ﹤0.01% | 952 |
|
|
2021
Q1 | $1.05M | Buy |
+42,115
| New | +$1.05M | ﹤0.01% | 1120 |
|